Aflibercept is effective in inhibiting vascular endothelial growth factor (VEGF) for a prolonged period of time, but possible side effects draw concerns about its long-term use in patients with age-related macular degeneration, diabetic macular oedema and retinal vein occlusion, according to the conclusions of a new study.
The duration and pattern of action of pain-suppressing nonsteroidal anti-inflammatory drugs (NSAIDs) used prior to photorefractive keratotomy (PRK) varies with the NSAID used, according to South Korean researchers.
A fixed combination of brinzolamide 1% and brimonidine 0.2% used twice a day lowers IOP significantly more than either drug alone and is as safe as either, according to results of a 6-month, Phase III study.
Inhibiting thrombin activity may be a treatment option for proliferative vitreoretinopathy (PVR), given that such activity is increased in the vitreous of patients with the disease and is associated with the activation of pro-inflammatory and pro-fibrotic pathways in retinal pigment epithelium (RPE) cells.
The European Commission has approved the eye drop suspension of brinzolamide 10 mg/mL and brimonidine tartrate 2 mg/mL to decrease elevated intraocular pressure (IOP) in adult patients who have open-angle glaucoma or ocular hypertension.
Light-adjustable intraocular lenses (IOLs) provide near-emmetropic refractive outcomes and good uncorrected distance visual acuity that remains stable over time, according to a recent study.
Oertli launches its new surgery platform for anterior and vitreoretinal procedures.
Aganirsen eye drops inhibited corneal neovascularization in patients with keratitis and reduced the need for transplantation in patients who have viral keratitis and central neovascularization, according to a Phase III study of 69 patients.
Acute glaucoma in mice is largely an inflammatory disease, and high intraocular pressure (IOP) causes vision loss by starting an inflammatory response similar to that caused by bacterial infections.
A guide to getting the most out of your stay during the XXXII Congress of the ESCRS.
Vasodilators and oral beta-blockers are associated with an increase in the hazard of incidence of early age-related macular degeneration (AMD) and exudative AMD, respectively, according to research recently published online.
Forty potential new treatments for inherited retinal diseases are under development, according to a review by the National Institute for Health Research (NIHR) Horizon Scanning Centre (HSC), working with charitable organization Fight for Sight.
A stable IOL, decreased pseudophacodonesis and improved graft fixation are the benefits of combining Descemet membrane endothelial keratoplasty with glued intrascleral haptic fixation of a posterior-chamber IOL in patients with aphakic or pseudophakic bullous keratopathy, according to recently published research.
Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research.
When detecting and evaluating the progression of glaucoma, Bruch's membrane opening-minimum rim width (BRO-MRW) may be the best predictor of the threshold of visual sensitivity and total deviation of visual field, according to a new study.
The systemic pharmacokinetics and pharmacodynamics of three anti-vascular endothelial growth factor (VEGF) treatments after they are administered intravitreally differ in ways that "may provide biological plausibility for potential differences in systemic safety risk," according to recently published research.
Removal of a cataract and implantation of an intraocular lens (IOL) improves overall sleep quality and sleep latency, according to a study published online before print.
In 2010, 2.1 million people were blind and 6 million people were visually impaired because of macular diseases other than diabetic maculopathy, according to a meta-analysis conducted by members of the Vision Loss Expert Group of the Global Burden of Disease Study Group.
Diurnal IOP curves have limited value in clinical practice for patients with primary open-angle glaucoma (POAG), according to a newly published study.
When performing corneal collagen crosslinking (CXL), ophthalmologists should monitor the keratoconus index and the index of height asymmetry garnered from the Scheimpflug camera, because changes in values of these indices are independent from initial corneal thickness.
It is relatively safe and effective for infants to undergo primary IOL implantation for the correction of aphakia after having one cataract removed, according to new research out of China.
Attaining a higher level of education and spending more years in school are associated with a greater prevalence and severity of myopia, according to a new study published online.
The addition of diquafosol tetrasodium (DQS) to a regimen of artificial tears and sodium hyaluronate helped relieve the symptoms of persistent dry eye in patients who had undergone laser in situ keratomileusis (LASIK), according to recent research.
The 32nd congress of the European Society of Cataract and Refractive Surgeons (ESCRS) is once again proving delectably inviting to the majority of the ophthalmology community. Not only is this the biggest event on the calendar but this year we will see it joining forces with EURETINA and EuCornea, which will surely ensure that it will be a busy and exciting congress.
In this article, Dr Kov?cs discusses his recent study evaluating whether femtosecond laser-assisted capsulotomy has an effect on the incidence of PCO when compared to the manual technique.
In this article, the authors discuss their research into alkylphosphocholine coated IOLs, which may offer some hope in the prevention of PCO in the future.
To address issues around ourcomes, dosing and safety of anti-VEGFs, an independent scientific symposium (sponsored by Novartis) was held during COPHy. Here, we present some brief highlights of this meeting.
A brief overview of some of the products that will be showcased during the ESCRS Congress
A diffractive trifocal IOL (FineVision, PhysIOL) provides a peak modulation transfer function for intermediate vision.
The AREDS 1 and 2 studies provide important information about the role of ocular nutrition in macular degeneration. However, to benefit patients, the findings must be condensed into clear and concise advice that will help them select appropriate vitamin supplements and follow a healthy lifestyle.